Neoadjuvant nab-paclitaxel and gemcitabine in borderline resectable or locally advanced unresectable pancreatic adenocarcinoma in patients who are ineligible for FOLFIRINOX

Shawn L. Peterson, Muhammad Husnain, Terri Pollack, Agustin Pimentel, Arturo Loaiza-Bonilla, Colleen Westendorf-Overley, Kelley Ratermann, Lowell Anthony, Philip Desimone, Gaurav Goel, Mahesh Kudrimoti, Sean Dineen, Ching Wei D. Tzeng, Peter J. Hosein

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant nab-paclitaxel and gemcitabine in borderline resectable or locally advanced unresectable pancreatic adenocarcinoma in patients who are ineligible for FOLFIRINOX'. Together they form a unique fingerprint.

Medicine & Life Sciences